{"id":4100,"date":"2021-01-22T13:24:29","date_gmt":"2021-01-22T18:24:29","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/hematology\/?p=4100"},"modified":"2021-01-26T13:29:30","modified_gmt":"2021-01-26T18:29:30","slug":"dr-shuaiying-cui-receives-sickle-cell-disease-advancing-cures-scd-ac-grant-supplement-from-doris-duke-charitable-foundation","status":"publish","type":"post","link":"https:\/\/www.bumc.bu.edu\/hematology\/2021\/01\/22\/dr-shuaiying-cui-receives-sickle-cell-disease-advancing-cures-scd-ac-grant-supplement-from-doris-duke-charitable-foundation\/","title":{"rendered":"Dr. Shuaiying Cui Receives Sickle Cell Disease\/Advancing Cures (SCD\/AC) Grant Supplement from Doris Duke Charitable Foundation"},"content":{"rendered":"<p><a href=\"\/hematology\/files\/2017\/03\/Cui-2.jpg\"><img loading=\"lazy\" src=\"\/hematology\/files\/2017\/03\/Cui-2-150x150.jpg\" alt=\"\" width=\"150\" height=\"150\" class=\"alignleft wp-image-1808 size-thumbnail\" srcset=\"https:\/\/www.bumc.bu.edu\/hematology\/files\/2017\/03\/Cui-2-150x150.jpg 150w, https:\/\/www.bumc.bu.edu\/hematology\/files\/2017\/03\/Cui-2-300x300.jpg 300w, https:\/\/www.bumc.bu.edu\/hematology\/files\/2017\/03\/Cui-2-768x768.jpg 768w, https:\/\/www.bumc.bu.edu\/hematology\/files\/2017\/03\/Cui-2-1024x1024.jpg 1024w, https:\/\/www.bumc.bu.edu\/hematology\/files\/2017\/03\/Cui-2.jpg 2048w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>Congratulations to <strong><span style=\"color: #003366;\">Dr. Shuaiying Cui<\/span> <\/strong>who recently received the Sickle Cell Disease\/Advancing Cures (SCD\/AC) grant supplement from the Doris Duke Charitable Foundation. The purpose of the additional funding totaling $77,000 is to examine the effects of two novel HbF inducers targeting on PGC-1a in human primary hematopoietic progenitor cells.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Congratulations to Dr. Shuaiying Cui who recently received the Sickle Cell Disease\/Advancing Cures (SCD\/AC) grant supplement from the Doris Duke Charitable Foundation. The purpose of the additional funding totaling $77,000 is to examine the effects of two novel HbF inducers targeting on PGC-1a in human primary hematopoietic progenitor cells.<\/p>\n","protected":false},"author":6467,"featured_media":1808,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[4124],"tags":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/posts\/4100"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/users\/6467"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/comments?post=4100"}],"version-history":[{"count":2,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/posts\/4100\/revisions"}],"predecessor-version":[{"id":4102,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/posts\/4100\/revisions\/4102"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/media\/1808"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/media?parent=4100"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/categories?post=4100"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/tags?post=4100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}